{"id":"NCT01967225","sponsor":"Bayer","briefTitle":"Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) Infections","officialTitle":"A Prospective, Randomized, Open-label, Active-controlled, Multicenter Study to Evaluate the Efficacy and Safety of BAY 1192631 in Japanese Patients With MRSA Infections (Skin and Soft Tissue Infection [SSTI] and SSTI-related Bacteremia)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-11-23","primaryCompletion":"2016-10-28","completion":"2016-10-28","firstPosted":"2013-10-22","resultsPosted":"2018-10-04","lastUpdate":"2018-10-04"},"enrollment":125,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Skin Diseases, Infectious"],"interventions":[{"type":"DRUG","name":"Tedizolid Phosphate (Sivextro, BAY1192631)","otherNames":[]},{"type":"DRUG","name":"Linezolid","otherNames":[]}],"arms":[{"label":"Tedizolid Phosphate (Sivextro, BAY1192631)","type":"EXPERIMENTAL"},{"label":"Linezolid","type":"ACTIVE_COMPARATOR"}],"summary":"The aim of this study is to see the efficacy and safety of BAY1192631 in Japanese patients with methicillin-resistant staphylococcus aureus (MRSA) (skin and soft tissue infections (SSTI) and SSTI-related bacteremia).","primaryOutcome":{"measure":"Clinical Response at Test of Cure (TOC)","timeFrame":"7-14 days after the end of treatment (EOT) for skin and soft tissue infections (SSTI) and 4-6 weeks after EOT for bacteremia","effectByArm":[{"arm":"Tedizolid Phosphate (Sivextro, BAY1192631) - SSTI","deltaMin":86.2,"sd":null},{"arm":"Linezoid - SSTI","deltaMin":80,"sd":null},{"arm":"Linezoid - Bacteremia","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":8},"locations":{"siteCount":46,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":83},"commonTop":["Dermatitis contact","Nausea","Injection site pain","Constipation","Diarrhoea"]}}